|
| VAERS ID: | 263215 | Vaccinated: | 2006-08-10 | | Age: | 18.0 | Onset: | 2006-08-10, Days after vaccination: 0 | | Gender: | Female | Submitted: | 2006-09-14, Days after onset: 35 | | Location: | California | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? Yes | | ER or Doctor Visit? No |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: NONE | | Previous Vaccinations: | | Other Medications: TRINESSA | | Preexisting Conditions: NONE | | CDC 'Split Type': WAES0608USA04457 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | 0702F | | IM | | |
| Administered by: Private Purchased by: Private | | Symptoms: Vomiting | | Write-up: Information has been received from a physician concerning an 18 year old female with no pertinent medical history or drug reactions/allergies, who on 10-AUG-2006 was vaccinated intramuscularly with HPV rLi 6 11 16 18 VLP vaccine (yeast) (0.5 ml) (lot#653650/0702F). Concomitant therapy included ethinyl estradiol/norgestimate (TRINESSA). On 10-AUG-2006 the patient experienced multiple episodes of vomiting. Unspecified medical attention was sought. Subsequently, the patient recovered from the vomiting within 48 hours. Additional information has been requested. |
|
|
| VAERS ID: | 263216 | Vaccinated: | 2006-08-17 | | Age: | 15.0 | Onset: | 2006-08-17, Days after vaccination: 0 | | Gender: | Female | Submitted: | 2006-09-14, Days after onset: 28 | | Location: | California | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? Yes | | ER or Doctor Visit? No |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: NONE | | Previous Vaccinations: | | Other Medications: NONE | | Preexisting Conditions: NONE | | CDC 'Split Type': WAES0608USA04465 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | 0702F | 0 | IM | AR | |
| Administered by: Private Purchased by: Private | | Symptoms: Nausea | | Write-up: Information has been received from a physician concerning a 15 year old female with no pertinent medical history or drug reactions/allergies, who on 17-AUG-2006 was vaccinated intramuscularly with HPV rLi 6 11 16 18 VLP vaccine (yeast) (0.5 ml) (lot#653650/0702F). There was no concomitant medication. On 17-aug-2006 the patient experienced nausea. Unspecified medical attention was sought. At the time of this report, the patient's nausea persisted. Additional information has been requested. This is in follow-up to report(s) previously submitted on 9/14/2006. Information has been received from a physician concerning a 15 year old female with no pertinent medical history or drug reactions/allergies, who on 17-AUG-2006 at 3:00 PM was vaccinated intramuscularly in the deltoid with the first dose of GARDASIL (lot # 653650/0702F). There were no illnesses at time of vaccination. There was no concomitant medication. On 17-AUG-2006 at 6:00 PM the patient experienced severe nausea. The patient subsequently recovered from the nausea on 21-AUG-2006. No further information is expected. |
|
|
| VAERS ID: | 263217 | Vaccinated: | 2006-08-18 | | Age: | 18.0 | Onset: | 2006-08-18, Days after vaccination: 0 | | Gender: | Female | Submitted: | 2006-09-14, Days after onset: 27 | | Location: | Massachusetts | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? Yes | | ER or Doctor Visit? Yes |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: NONE | | Previous Vaccinations: | | Other Medications: NONE | | Preexisting Conditions: NONE | | CDC 'Split Type': WAES0608USA04485 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | 0702F | | IM | | |
| Administered by: Other Purchased by: Other | | Symptoms: Injection site pain, Syncope | | Write-up: Information has been received from a nurse concerning an 18 year old female with no known allergies and no other pertinent medical history reported. On 18-AUG-2006, the patient was vaccinated intramuscularly in the deltoid with a 0.5 ml "single dose prefilled syringe" of HPV rLi 6 11 16 18 VLP vaccine (yeast) (Lot#653650/0702F). There were no concomitant medication reported. On 18-AUG-2006, the patient developed severe injection site pain with HPV rLi 6 11 16 18 VLP vaccine (yeast) injection. The patient remarked that "it hurt and felt that the injection went to her head". The nurse reported that the patient felt faint immediately after the vaccination. The nurse had the patient lay down. It was reported that the patient "got up after 1 minute and said that she was ok.". The nurse reported that the "patient left the office immediately after this and the nurse was following up with the patient later today to make sure that the patient was ok." The nurse reported that she had not agitated the syringe prior to injection. The patient sought unspecified medical attention. There were no laboratory diagnostic studies performed. On 18-AUG-2006, the patient recovered from the events. Additional information has been requested. |
|
|
| VAERS ID: | 263218 | Vaccinated: | 2006-07-27 | | Age: | 52.0 | Onset: | 2006-07-27, Days after vaccination: 0 | | Gender: | Female | Submitted: | 2007-01-06, Days after onset: 163 | | Location: | California | Entered: | 2006-09-19, Days after submission: 109 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? Yes | | ER or Doctor Visit? Yes |
| Hospitalized? No | | Current Illness: Herpes labialis | | Diagnostic Lab Data: Unknown | | Previous Vaccinations: | | Other Medications: | | Preexisting Conditions: Herpes virus infection | | CDC 'Split Type': WAES0608USA04520 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | | 0 | IM | | |
| Administered by: Private Purchased by: Other | | Symptoms: Injection site reaction | | Write-up: This is in follow-up to report(s) previously submitted on 9/14/2006. Initial and follow-up information has been received from a physician concerning a 52 year old female with a history of a "herpes outbreak" two weeks ago. On 17-JUL-2006. "10 days prior" to receiving GARDASIL (yeast), the patient had taken acyclovir 200 mg. On 27-JUL-2006, the patient was vaccinated intramuscularly with the first dose of 0.5 mL of GARDASIL (yeast). It was reported that the patient had "2 herpes lesions on her inner labia" at the time of vaccination. On 27-JUL-2006, the patient developed a neck ache, eyelashes fell out, "a decrease memory for people" and excessive dry eye. On 27-AUG-2006 the patient developed a migraine with vomiting (previously reported that the patient had "burning at the injection site"). The patient sought unspecified medical attention. At the time of this report, the patient had recovered from the events (date unknown). Additional information has been requested. |
|
|
| VAERS ID: | 263219 | Vaccinated: | 0000-00-00 | | Age: | | Onset: | 0000-00-00 | | Gender: | Female | Submitted: | 2006-09-14 | | Location: | California | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? Yes | | ER or Doctor Visit? Yes |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: Unknown | | Previous Vaccinations: | | Other Medications: Unknown | | Preexisting Conditions: Unknown | | CDC 'Split Type': WAES0608USA05355 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | | 0 | IM | | |
| Administered by: Other Purchased by: Other | | Symptoms: Influenza like illness | | Write-up: Information has been received from a physician concerning a female (age not reported) who on an unspecified date, was vaccinated intramuscularly with the first dose of 0.5 ml of HPV rLi 6 11 16 18 VLP vaccine (yeast). The day after receiving HPV rLi 6 11 16 18 VLP vaccine (yeast), the patient developed "flu-like symptoms" (date unknown). The patient sought unspecified medical attention. At the time of this report, the patient had recovered from the event (date unknown). Additional information has been requested. |
|
|
| VAERS ID: | 263220 | Vaccinated: | 2006-08-21 | | Age: | 22.0 | Onset: | 2006-08-21, Days after vaccination: 0 | | Gender: | Female | Submitted: | 2006-09-14, Days after onset: 24 | | Location: | Illinois | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? No | | ER or Doctor Visit? Yes |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: NONE | | Previous Vaccinations: | | Other Medications: ORTHO TRI CYCLEN | | Preexisting Conditions: CONCURRENT CONDITIONS: drug hypersensitivity | | CDC 'Split Type': WAES0608USA05414 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | | | | UN | |
| Administered by: Other Purchased by: Other | | Symptoms: Loss of consciousness | | Write-up: Information has been received from a 22 year old female with an allergy to meperidine hydrochloride (DEMEROL) who on 21-AUG-2006 was vaccinated with HPV rLi 6 11 16 18 VLP vaccine (yeast). Concomitant therapy included ethinyl estradiol/norgestimate (ORTHO TRI CYCLEN). On 21-AUG-2006, following the vaccination, the patient fainted. Unspecified medical attention was sought. At the time of this report, the patient was recovering. Additional information has been requested. |
|
|
| VAERS ID: | 263221 | Vaccinated: | 0000-00-00 | | Age: | | Onset: | 0000-00-00 | | Gender: | Female | Submitted: | 2006-09-14 | | Location: | Arizona | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? No | | ER or Doctor Visit? Yes |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: Unknown | | Previous Vaccinations: | | Other Medications: Unknown | | Preexisting Conditions: Unknown | | CDC 'Split Type': WAES0609USA00390 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | | 1 | IM | | |
| Administered by: Other Purchased by: Other | | Symptoms: Injection site vesicles | | Write-up: Information has been received from a registered nurse concerning a female patient who in 2006 was vaccinated with her first dose of HPV rLi 6 11 16 18 VLP vaccine (yeast). Subsequently, she was vaccinated with her second dose of HPV rLi 6 11 16 18 VLP vaccine (yeast). Subsequently, she developed a blister at the injection site. Medical attention was sought. The patient's outcome was unknown. Additional information has been requested. Follow-up informatin received 4-11-08, indicated that the patient was being treated with an unspecified vaccine, and not Gardasil as previously reported. Therefore, WAES #0609USA00390 is being deleted from our files on HPV rL1 6 11 16 8 VLP vaccine (yeast). This report was previously sent to PLA V501 on 09/14/06. |
|
|
| VAERS ID: | 263222 | Vaccinated: | 0000-00-00 | | Age: | | Onset: | 0000-00-00 | | Gender: | Female | Submitted: | 2006-09-14 | | Location: | Arizona | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? No | | ER or Doctor Visit? Yes |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: Unknown | | Previous Vaccinations: | | Other Medications: Unknown | | Preexisting Conditions: Unknown | | CDC 'Split Type': WAES0609USA00391 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | | 1 | IM | UN | |
| Administered by: Other Purchased by: Other | | Symptoms: Injection site vesicles | | Write-up: Information has been received from a registered nurse concerning a female patient who in 2006 was vaccinated with her first dose of GARDASIL. Subsequently, she was vaccinated with her second dose of GARDASIL (yeast). Subsequently, she developed a blister at the injection site. Medical attention was sought. The patient's outcome was unknown. Additional information has been requested. Follow up information indicated that the patient was being treated with an unspecified vaccine, and not GARDASIL as previously reported. Therefore, WAES #0609USA00391 is being deleted from our files on GARDASIL. This report was previously sent to PLA V501 on 14-SEP-2006. |
|
|
| VAERS ID: | 263223 | Vaccinated: | 2006-08-08 | | Age: | | Onset: | 2006-08-11, Days after vaccination: 3 | | Gender: | Female | Submitted: | 2006-09-14, Days after onset: 34 | | Location: | Unknown | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? No | | ER or Doctor Visit? No |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: | | Previous Vaccinations: | | Other Medications: Unknown | | Preexisting Conditions: Unknown | | CDC 'Split Type': WAES0609USA01112 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | | | IM | | |
| Administered by: Other Purchased by: Other | | Symptoms: Unevaluable event | | Write-up: Information has been received from a nurse concerning two female patients who on approximately 08-AUG-2006 were vaccinated with HPV rLi 6 11 16 18 VLP vaccine (yeast). |
|
|
| VAERS ID: | 263224 | Vaccinated: | 0000-00-00 | | Age: | | Onset: | 0000-00-00 | | Gender: | Female | Submitted: | 2006-09-14 | | Location: | Unknown | Entered: | 2006-09-19, Days after submission: 5 | |
| Life Threatening Illness? No |
| Died? No |
| Disability? No |
| Recovered? No | | ER or Doctor Visit? No |
| Hospitalized? No | | Current Illness: | | Diagnostic Lab Data: Unknown | | Previous Vaccinations: | | Other Medications: Unknown | | Preexisting Conditions: Unknown | | CDC 'Split Type': WAES0608USA05808 | |
| Vaccination | Manufacturer | Lot | Dose | Route | Site | | HPV4 | MERCK & CO. INC. | | | IM | | |
| Administered by: Other Purchased by: Other | | Symptoms: Injection site pain | | Write-up: Information has been received from a licensed practical nurse concerning female college students 9exact number of patients unspecified) who were vaccinated intramuscularly with HPV rLi 6 11 16 18 VLP vaccine (yeast). Subsequently the patients experienced injection site (deltoid) pain. At the time of this report, the outcome of the event was unknown. Further attempts are being made to identify the exact number of patients and identifiers of the patients involved in this report. |
|
|